Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta‐analysis

ConclusionsPindolol augmentation may not be suitable for treatment‐resistant depression patients with SSRI‐resistant depression. However, once‐daily high‐dose pindolol (7.5 mg qd) appears to show a promising benefit in these patients. Copyright © 2015 John Wiley & Sons, Ltd.

Source: Human Psychopharmacology: Clinical and Experimental - January 1, 2015 Category: Psychiatry Authors: Yiyun Liu, Xinyu Zhou, Dan Zhu, Jianjun Chen, Bin Qin, Yuqing Zhang, Xiao Wang, Deyu Yang, Huaqing Meng, Qinghua Luo, Peng Xie Tags: Review Article Source Type: research